Browse our anti-GIP (GIP) Antibodies

Full name:
anti-Gastric Inhibitory Polypeptide Antibodies (GIP)
On are 104 Gastric Inhibitory Polypeptide (GIP) Antibodies from 18 different suppliers available. Additionally we are shipping GIP Kits (54) and GIP Proteins (9) and many more products for this protein. A total of 198 GIP products are currently listed.
1810036L03Rik, AW558049, DF5L, Dfna5l, GIP, Gludins, Gsdmdc1, M2-4, Nif3, NLIIF, RATGLUDINS, SCP1, wu:fb66d03, wu:fd19c08, xgip, xx:sd49

Most Popular Reactivities for anti-GIP (GIP) Antibodies

Select your species and application

anti-Mouse (Murine) GIP Antibodies:

anti-Human GIP Antibodies:

anti-Rat (Rattus) GIP Antibodies:

All available anti-GIP Antibodies

Go to our pre-filtered search.

Top referenced anti-GIP Antibodies

  1. Human Polyclonal GIP Primary Antibody for IHC (fro), IF - ABIN115738 : Portela-Gomes, Stridsberg, Johansson, Grimelius: Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1997 (PubMed)

  2. Human Monoclonal GIP Primary Antibody for ICC, IF - ABIN449439 : Banerjee, Zoetewey, Ovee, Mazumder, Petrenko, Samoylova, Mohanty: Specificity and promiscuity in human glutaminase interacting protein recognition: insight from the binding of the internal and C-terminal motif. in Biochemistry 2012 (PubMed)

  3. Human Polyclonal GIP Primary Antibody for IHC, ELISA - ABIN1584506 : Chang, Cai, Lo, Amigo, Park, Hsu: Adaptive selection of an incretin gene in Eurasian populations. in Genome research 2011 (PubMed)

More Antibodies against GIP Interaction Partners

Mouse (Murine) Gastric Inhibitory Polypeptide (GIP) interaction partners

  1. these findings identify distinct roles for DPP4 (show DPP4 Antibodies) in the endothelial cell versus the bone marrow compartment for selective incretin degradation and DPP4 (show DPP4 Antibodies) inhibition-mediated glucoregulation.

  2. These results strongly suggest that incretins upregulate the TNF-alpha-stimulated IL6 synthesis in osteoblasts, and that the amplifying effect of incretin is exerted via reducing the IkappaB/NFkappaB pathway through the adenylyl cyclase-cAMP system.

  3. It was demonstrated that cardiomyocytes represent a direct target of GIP action in vitro, and that GIP ameliorated AngII-induced cardiac hypertrophy via suppression of cardiomyocyte enlargement, apoptosis, and fibrosis in vivo.

  4. Galanin (show GAL Antibodies), acting via the GAL1 (show LGALS1 Antibodies) receptor and Gi -coupled signalling in L and K cells, is a potent inhibitor of GLP-1 (show GCG Antibodies) and GIP secretion

  5. The loss of food-induced GIP response in Roux-limb of intestine likely contributes to the attenuated serum GIP response to feeding.

  6. GIP induces the expression of the proatherogenic cytokine osteopontin (OPN) in mouse arteries via local release of endothelin-1 and activation of CREB. GIPR mRNA is higher in symptomatic carotid endarterectomy patients.

  7. These studies support the hypothesis that a reduction in GIP signaling using a GIP-neutralizing mAb might provide a useful method for the treatment and prevention of obesity and related disorders.

  8. This study provides evidences that GIP acts directly on osteoblasts and is capable of improving collagen maturity and fibril diameter.

  9. There was decrease in GIP gene transcripts and protein in the gut (show GUSB Antibodies) of HNF1a (show HNF1A Antibodies)-null mice.

  10. The patterns of colocalisation of the K cell marker, glucagon-like insulinotropic peptide, and the L cell markers, glucagon like peptide-1 and peptide YY, in enteroendocrine cells of the small intestine and colon of mouse and pig, were investigated.

Human Gastric Inhibitory Polypeptide (GIP) interaction partners

  1. GIP and PP plasma concentrations are lower in pancreatic cancer irrespective of the degree of glucose intolerance as compared to Type 2 diabetic patients and healthy controls.

  2. Evening postprandial insulin (show INS Antibodies) and GIP responses and insulin (show INS Antibodies) resistance declined by over 30% after three meals that limited daily carbohydrate intake to 30% compared to no such changes after three 60%-carbohydrate meals, an effect that was independent of pre-meal exercise.

  3. the stimulatory effect of IGF-1 (show IGF1 Antibodies) on GIP promoter support the hypothesis of a functional growth hormone (show GH1 Antibodies)-igf-1 (show IGF1 Antibodies)-GIP axis

  4. decreased maternal 25OHD may be associated with decreased cord 25OHD and increased cord GLP-1 (show GCG Antibodies) and GIP levels, which may be involved with the transfer of maternal glucose to the fetus

  5. Excess androgen activity might be a factor contributing to alter secretion of incretins in lean polycystic ovary syndrome (PCOS) women. However it could not be ruled out that it is also possible that increased GIP levels might induce hyperandrogenemia in PCOS.

  6. Our results might indicate an altered DPP4 (show DPP4 Antibodies)-incretin system and altered immunoregulation including a potentially dysfunctional GLP1 (show GCG Antibodies)(9)(-)(36) signaling in T1DM.

  7. Fasting GIP concentrations are higher in individuals with a history of cardiovascular disease (myocardial infarction, stroke) when compared with control subjects.

  8. Data suggest that high levels of blood glucose or AGEs (advanced glycation end products), as seen in hyperglycemia, reduce secretion of insulin (show INS Antibodies) by pancreatic beta cells via antagonism of GIP (gastric inhibitory polypeptide)/GIP receptor signaling.

  9. Data confirm that postprandial plasma levels of glucose-dependent insulinotropic polypeptide (GIP) and insulin (INS (show INS Antibodies)) are responsive to glycemic index of foods consumed; glycemic index of breakfast cereals regulate plasma postprandial GIP and INS (show INS Antibodies).

  10. irisin (show FNDC5 Antibodies) and GIP might contribute to the development of polycystic ovary syndrome and may also represent novel polycystic ovary syndrome biomarkers

Pig (Porcine) Gastric Inhibitory Polypeptide (GIP) interaction partners

  1. porcine GIP stimulated the proliferation of MC-26 cells, a mouse CRC (show RYR1 Antibodies) cell line, in a concentration-dependent manner.

  2. The patterns of colocalisation of the K cell marker, glucagon-like insulinotropic peptide, and the L cell markers, glucagon like peptide-1 and peptide YY, in enteroendocrine cells of the small intestine and colon of mouse and pig, were investigated.

GIP Antigen Profile

Antigen Summary

Preferentially catalyzes the dephosphorylation of 'Ser- 5' within the tandem 7 residues repeats in the C-terminal domain (CTD) of the largest RNA polymerase II subunit POLR2A. Negatively regulates RNA polymerase II transcription, possibly by controlling the transition from initiation/capping to processive transcript elongation (By similarity). Recruited by REST to neuronal genes that contain RE-1 elements, leading to neuronal gene silencing in non-neuronal cells.

Alternative names and synonyms associated with GIP

  • gasdermin D (Gsdmd) antibody
  • apolipoprotein A-Ib (apoa1b) antibody
  • gastric inhibitory polypeptide (GIP) antibody
  • gastric inhibitory polypeptide (gip) antibody
  • CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 (Ctdsp1) antibody
  • gastric inhibitory polypeptide (Gip) antibody
  • gastric inhibitory polypeptide-like (LOC100350350) antibody
  • gastric inhibitory polypeptide-like (LOC100621117) antibody
  • gastric inhibitory polypeptide-like (LOC100856162) antibody
  • 1810036L03Rik antibody
  • AW558049 antibody
  • DF5L antibody
  • Dfna5l antibody
  • GIP antibody
  • Gludins antibody
  • Gsdmdc1 antibody
  • M2-4 antibody
  • Nif3 antibody
  • NLIIF antibody
  • RATGLUDINS antibody
  • SCP1 antibody
  • wu:fb66d03 antibody
  • wu:fd19c08 antibody
  • xgip antibody
  • xx:sd49 antibody

Protein level used designations for GIP

gasdermin domain containing 1 , gasdermin domain-containing protein 1 , gasdermin-D , gastric inhibitory polypeptide , glucose-dependent insulinotropic polypeptide , NLI-interacting factor 3 , carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 , golli-interacting protein , nuclear LIM interactor-interacting factor 3 , small C-terminal domain phosphatase 1 , small CTD phosphatase 1 , incretin hormone , Glucose-dependent insulinotropic peptide

100718575 Mus musculus
100101640 Danio rerio
749143 Pan troglodytes
100036740 Xenopus (Silurana) tropicalis
698335 Macaca mulatta
609020 Canis lupus familiaris
100037247 Xenopus laevis
227292 Mus musculus
2695 Homo sapiens
100533199 Sus scrofa
25040 Rattus norvegicus
14607 Mus musculus
511073 Bos taurus
419989 Gallus gallus
101113509 Ovis aries
100350350 Oryctolagus cuniculus
100621117 Sus scrofa
100856162 Canis lupus familiaris
Selected quality suppliers for anti-GIP (GIP) Antibodies
Did you look for something else?